← ANALYSTS · TIPRANKS
Douglas Miehm · RBC Capital
Hits
51%
162 of 317 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+5.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
6
Buy / hold / sell: 3 / 3 / 0
Upside of the analyst’s targets
+8.4%
Average over 6 current targets, to the last price
The market’s answer to the ratings
+2.7%
Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 8on TipRanks Oct 9 08:35 | PCRXIWMPacira Pharmaceuticals · $1.4B | Assigned | Hold | $25.00 → $36.50+46.0% | +0.4% | +44.8%next day −0.8% · 5 days +0.1% | ↗ |
| Oct 8on TipRanks 08:25 | BLCOBausch + Lomb Corporation · $6.2B | Reiterated | Buy | $21.00 | +27.3% | −0.7%next day +0.3% · 5 days −2.6% | ↗ |
| Aug 9on TipRanks Aug 10 07:25 | LGNDIWMLigand Pharma · $6.0B | Reiterated | Buy | $345 | +16.7% | +0.9%next day −2.0% · 5 days −1.3% | ↗ |
| Aug 7on TipRanks 07:06 | AUPHIWMAurinia Pharmaceuticals · $2.2B | Reiterated | Hold | $15.00 → $16.00+6.7% | −3.1% | −2.3%next day −2.5% · 5 days −2.8% | ↗ |
| Aug 6on TipRanks 07:25 | MNKDIWMMannKind · $971M | Reiterated | Hold | $4.75 | +56.2% | −5.0%next day +5.0% · 5 days −5.3% | ↗ |
| Aug 5on TipRanks 07:42 | PCRXIWMPacira Pharmaceuticals · $1.4B | Reiterated | Hold | $24.00 → $25.00+4.2% | −31.2% | −9.8%next day +3.0% · 5 days −5.1% | ↗ |
| Jul 30on TipRanks Jul 31 10:36 | BLCOBausch + Lomb Corporation · $6.2B | Reiterated | Buy | $21.00 | +27.3% | +3.2%next day −1.2% · 5 days −7.4% | ↗ |
| Mar 19on TipRanks Mar 20 07:30 | VHIIWMValhi · $406M | Reiterated | Buy | $8.45 → $7.75−8.3% | −47.2% | +2.3%next day −1.2% · 5 days +6.8% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗